Use of erythromycin for the treatment of severe chronic constipation in children
The efficacy of erythromycin was assessed in the treatment of 14 children aged 4 to 13 years with refractory chronic constipation, and presenting megarectum and fecal impaction. A double-blind, placebo- controlled, crossover study was conducted at the Pediatric Gastroenterology Outpatient Clinic of...
Main Authors: | M.A. Bellomo-Brandão, E.F. Collares, E.A.L. da-Costa-Pinto |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2003-10-01
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2003001000016 |
Similar Items
-
Erythromycin: safety issues
by: Matveev A.V., et al.
Published: (2018-08-01) -
Clinical and pathogenetic variants of antroduodenal motility disorders in children and their medicinal correction
by: A. I. Khavkin, et al.
Published: (2016-03-01) -
Current developments in pharmacological therapeutics for chronic constipation
by: Chunhuan Jiang, et al.
Published: (2015-07-01) -
Patient considerations in the management of chronic constipation: focus on prucalopride
by: Shin A
Published: (2016-07-01) -
Current Status of Translational Research on Constipation
by: Hyun Jik Lee, et al.
Published: (2016-09-01)